DP018 | HYPOMETHYLATING AGENTS ALONE STILL HAVE A ROLE IN ACUTE MYELOID LEUKEMIA TREATMENT: RESULTS OF A RETROSPECTIVE REAL-LIFE STUDY ON 132 PATIENTS.

Decitabine (DEC) and Azacitidine (AZA) alone or in combination with Venetoclax (VEN) represent the gold standard treatment for unfit patients (pts) with acute myeloid leukemia (AML). As these two strategies differ in terms of efficacy (greater with HMAs-VEN combination) and tolerability (better wit...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	R. Palmieri, F. Pilo, M. Pettinau, G. Paterno, F. Mallegni, E. Meddi, F. Moretti, I. Cerroni, M.I. Del Principe, L. Maurillo, G. Caocci, A. Venditti
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Ferrata Storti Foundation 2025-09-01
Σειρά:	Haematologica
Διαθέσιμο Online:	https://haematologica.org/article/view/12782
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!